Compare Charles River Laboratories Intl. Inc (CRL) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Alliant Energy Corporation — how do they compare? Charles River Laboratories Intl. Inc trades at $302.66 (market cap $14.23B), while Alliant Energy Corporation trades at $65.58 (market cap $16.99B). The key difference: Alliant Energy Corporation is the larger of the two by market cap, and Alliant Energy Corporation pays a 3.27% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Alliant Energy Corporation for 64 Days on average.
| CRL | LNT | |
|---|---|---|
Market Cap | $14.23B | $16.99B |
Volume | 1,176,885 | 2,488,387 |
Sector | Health | Utilities |
52-Week High | $310.77 | $78.03 |
52-Week Low | $149.93 | $63.21 |
Typical Hold Time | 33 Days | 64 Days |
Enterprise Value | $17.06B | $29.08B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
LNT trades at $65.21, down 0.43% on the day, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 EPS of $0.65, beating estimates, and maintains a strong profitability profile with an 18.45% net income margin. Recent news highlights institutional buying and a $1.4 billion partnership expansion, though the stock recently touched a 52-week low.
The outlook is supported by a $13.4 billion capital investment plan and data center demand growth, offering potential upside to the $77 consensus price target. Risks include rising debt levels and cost pressures, but analyst sentiment remains positive with no sell ratings. The stock presents a defensive income opportunity with a growing dividend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
